Imago BioSciences, Inc. (IMGO): Price and Financial Metrics
IMGO Price/Volume Stats
| Current price | $36.01 | 52-week high | $36.09 |
| Prev. close | $36.00 | 52-week low | $11.56 |
| Day low | $35.99 | Volume | 139,300 |
| Day high | $36.02 | Avg. volume | 171,367 |
| 50-day MA | $29.83 | Dividend yield | N/A |
| 200-day MA | $19.59 | Market Cap | 1.22B |
IMGO Stock Price Chart Interactive Chart >
Imago BioSciences, Inc. (IMGO) Company Bio
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
IMGO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 117.85% |
| 5-year | N/A |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | 51.62% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...